Intrinsic Value of S&P & Nasdaq Contact Us

LumiraDx Limited LMDX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • GB • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+9275%

LumiraDx Limited (LMDX) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.

The consensus price target is $1.50, representing an upside of 9275% from the current price $0.02.

LMDX Stock — 12-Month Price Forecast

$1.50
▲ +9,275.00% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for LumiraDx Limited, the price target is $1.50.
The average price target represents a +9,275.00% change from the last price of $0.02.

LMDX Analyst Ratings

Buy
4
Ratings
3 Buy
1 Hold
Based on 4 analysts giving stock ratings to LumiraDx Limited in the past 3 months
Rating breakdown
Buy
3 75%
Hold
1 25%
75%
Buy
3 analysts
25%
Hold
1 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message